A Phase II Study of Epothilone B Analog BMS-247550 in Patients With Taxane-Resistant Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Ixabepilone (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2009 Actual end date (January 2003) added as reported by ClinicalTrials.gov record.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2005 New trial record.